Autism Spectrum Disorder
📧 Sign up to get email alerts when something new happens for Autism Spectrum Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Intensive Intervention for Toddlers With Autism (EARLY STEPS) [NA]
Clinical trial update for the EARLY STEPS intensive intervention program for toddlers with autism, completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: Neural and Behavioral Effects of Oxytocin in Autism Spectrum Disorders [Phase 4]
Phase 4 trial evaluating neural and behavioral effects of oxytocin in autism spectrum disorders has completed with results posted.
-
FDA approval · 2020-02-05FDA Approved: RISPERDAL — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Risperdal (risperidone) from Janssen Pharmaceuticals, Inc. The action updates the product la…
-
FDA approval · 2020-02-05FDA Approved: ARIPIPRAZOLE — Supplemental Application (Lannett Company, Inc.)
The FDA approves a supplemental application for ARIPIPRAZOLE (Aripiprazole) from Lannett Company, expanding approval of a generic antipsycho…
-
FDA approval · 2020-02-05FDA Approved: ARIPIPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved Dr. Reddy's supplemental application to manufacture and market aripiprazole orally disintegrating tablets as a generic product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Modulating Socially Adaptive Mirror System Functioning in Autism by Oxytocin [Phase 3]
Phase 3 trial assessing oxytocin to modulate social functioning in autism has completed.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: ASD Parent Trainer: Online Coaching for Parents of Children With Autism [NA]
Clinical trial update for an online coaching program for parents of children with autism; study completed with results posted in 2020.
-
FDA approval · 2020-02-05FDA Approved: ARIPIPRAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approves a supplemental application for a generic version of aripiprazole from Alembic Pharmaceuticals Inc.
-
FDA approval · 2020-02-04FDA Approved: ARIPIPRAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' supplemental application to market a generic ARIPIPRAZOLE under an ANDA.
-
FDA approval · 2020-02-04FDA Approved: ARIPIPRAZOLE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ARIPIPRAZOLE from Aurobindo Pharma Limited, indicating regulatory clearance for changes to the a…
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: A Randomized, Controlled Trial of Intranasal Oxytocin as an Adjunct to Behavioral Therapy for Autism Spectrum Disorder [Phase 2]
Phase 2 randomized trial evaluating intranasal oxytocin as an adjunct to behavioral therapy for autism spectrum disorder has been completed.
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Cord Blood Infusion for Children With Autism Spectrum Disorder [Phase 2]
Phase 2 trial investigating cord blood infusion for children with autism spectrum disorder has completed with results posted.
-
FDA approval · 2019-12-26FDA Approved: ARIPIPRAZOLE — Original Application (VistaPharm, LLC)
FDA approved VistaPharm, LLC's original ANDA (212870) for a generic aripiprazole. This approval makes a generic version of aripiprazole avai…
-
FDA approval · 2019-12-22FDA Approved: RISPERIDONE — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved a supplemental application for risperidone by Jubilant Cadista Pharmaceuticals Inc. This approval pertains to changes to the ap…
-
CLINICAL_TRIALS trial_result · 2019-12-20Clinical Trial Update: A Trial of TTA-121 on Autism Spectrum Disorder [Phase 2]
Phase 2 clinical trial update for TTA-121 in Autism Spectrum Disorder.
-
CLINICAL_TRIALS trial_result · 2019-12-20Clinical Trial Update: Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD
Clinical trial update for MITA, an early intervention language training program for children with autism spectrum disorder, completed with r…
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Pediatric Open-Label Extension Study [Phase 3]
Phase 3 pediatric open-label extension study completed; results posted in 2019 for schizophrenia and autism conditions.
-
CLINICAL_TRIALS trial_result · 2019-12-18Clinical Trial Update: Beneficial Bacteria Treatment for Autism [Phase 1, Phase 2]
This clinical trial update reports Phase 1 and Phase 2 results for a beneficial bacteria treatment being studied for autism spectrum disorde…
-
FDA approval · 2019-12-10FDA Approved: ARIPIPRAZOLE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for ARIPIPRAZOLE from Amneal Pharmaceuticals LLC (aripiprazole).
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: Training Attention and Eye Movement in ASD [NA]
Clinical trial about training attention and eye movement in autism spectrum disorders has completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Folinic Acid in Autism [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating folinic acid in autism has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: Evaluation of Project TEAM (Teens Making Environmental and Activity Modifications) [NA]
Clinical trial record for Project TEAM evaluating environmental and activity modifications in transition-age youth with developmental disabi…
-
CLINICAL_TRIALS trial_result · 2019-11-20Clinical Trial Update: The Family VOICE Study [NA]
Completed clinical trial (The Family VOICE Study) with results posted in 2019; conditions include autism and aggression among others listed.
-
FDA approval · 2019-11-12FDA Approved: RISPERIDONE — Supplemental Application (Ajanta Pharma USA Inc.)
The FDA approved Ajanta Pharma USA Inc.'s supplemental application for risperidone, authorizing a generic version of the antipsychotic.
-
CLINICAL_TRIALS trial_result · 2019-10-28Clinical Trial Update: Oxytocin in Adolescents With Autism Spectrum Disorders [Phase 2, Phase 3]
Clinical trial update for oxytocin in adolescents with autism spectrum disorder, involving Phase 2 and Phase 3 cohorts; the study status is …